| Serial Number | 79397997 |
| Word Mark | CHASING CURES. DELIVERING HOPE. |
| Filing Date | Thursday, February 22, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, March 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 1, 2025 |
| Goods and Services | Pharmaceutical and biotechnological preparations and substances being pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; drug delivery agents consisting of compounds, namely, liposomes and viral particles that facilitate delivery of a wide range of pharmaceuticals |
| Goods and Services | Medical instruments and apparatus for use in surgery; medical instruments and apparatus, namely, clamps for surgical use, surgical retractors, surgical platforms, surgical stabilizers, and surgical manipulator arms; medical diagnostic instruments and apparatus for the diagnosis of neurological diseases and disorders, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological diseases and disorders, sold without medication; implantable drug delivery devices, namely, implantable drug delivery pumps and implantable drug delivery ports |
| Goods and Services | Scientific and technological services, namely, research and design in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; design and development of computer hardware and software; scientific research and development, biological research and development, clinical research and development, medical research and development; research, development and testing relating to pharmaceutical and biotechnological preparations and substances; research, development and testing relating to medical and scientific instruments and apparatus; research, development and testing relating to neurological therapeutics, diseases and disorders; design and development of medical diagnostic apparatus; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical and biotechnological preparations and substances; scientific research in the nature of conducting clinical trials for others in the fields of neurological therapeutics, diseases and disorders; scientific research in the nature of conducting clinical trials for others in the fields of medical and scientific instruments and apparatus; providing online, non-downloadable software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for analysing clinical information; providing online, non-downloadable software for diagnosis of neurological diseases and disorders; providing online, non-downloadable software for operating medical instruments and apparatus; providing online, non-downloadable software for connecting machines and medical instruments and apparatus; providing online, non-downloadable software for collecting and exchanging information and data; providing online, non-downloadable software for monitoring medical instruments and apparatus and interfacing with the cloud; providing online, non-downloadable software for mobile devices, smartphones, tablet computers, personal computers and televisions for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for transmitting, sharing, receiving, streaming, downloading, playing, organizing, displaying, collecting and transferring information, data, audio, video, images, content and other multimedia content between devices via the internet, over a wireless network and other communications networks; providing online, non-downloadable software for the remote control of machines and medical instruments and apparatus; providing online, non-downloadable software for facilitating cloud computing services; information technology services, namely, technical consulting services relating to the technology fields of medical and scientific instruments and apparatus; information technology services, namely, technical consulting services relating to the technology fields of pharmaceutical and biotechnological preparations and substances; advisory and consulting services related to the aforegoing services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aviadobio Ltd |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | London E14 5GX GB |
| Party Name | Aviadobio Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, June 20, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 21, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 9, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Wednesday, September 11, 2024 | ASSIGNED TO EXAMINER |
| Friday, September 13, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, September 14, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 16, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, September 16, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, October 7, 2024 | REFUSAL PROCESSED BY IB |
| Friday, February 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 10, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 10, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 10, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 10, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 10, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |